Back to top

genomics: Archive

Ekta Bagri

3 Top Genomics Stocks to Add to Your Portfolio in 2025

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - Intellia Therapeutics (NTLA), uniQure (QURE) and Verve Therapeutics (VERV).

ILMNNegative Net Change BEAMNegative Net Change QURENegative Net Change NTLANo Net Change CRSPPositive Net Change

Zacks Equity Research

REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research

Regeneron is set to acquire 23andMe assets for $256 million to boost genetic drug discovery. The transaction is expected to close by third-quarter 2025.

REGNNegative Net Change BAYRYNegative Net Change HALONegative Net Change ALLONegative Net Change